Spectrum Pharmaceuticals lowers stockholder meeting quorum to 33 1/3%

SPECTRUM PHARMACEUTICALS INC

Board approved Fourth Amended and Restated Bylaws effective March 30, 2023.
Quorum reduced from a majority to 33 1/3% of outstanding voting shares.
Change applies to all stockholder meetings for transaction of business.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

SPECTRUM PHARMACEUTICALS INC: Amended quorum requirement for stockholder meetings from majority to 33 1/3% of issued and outstanding shares (effective 2023-03-30).

Change: bylaw amendment
Effective: 2023-03-30

Exact text from the filing

The Restated Bylaws amended the quorum requirement for the transaction of business at all meetings of stockholders from the holders of a majority, to the holders of 33 1/3%, of the Company’s issued and outstanding shares of stock entitled to vote thereat, present in person or represented by proxy.

View on SEC.gov

Browse all governance changes →

Source: SEC EDGAR

accession 0001193125-23-090847

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.